Sandford D. Smith, Director at APRICUS BIOSCIENCES, INC. (APRI), bought 26,500 shares at $1.52 ($42K) on 2014-10-22, disclosed to the SEC on 2014-10-24.
Open-market purchase of $42k APRI by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.52 | 8,300 | $13K | 30.4% |
| 2 | $1.59 | 18,200 | $29K | 69.6% |
| Total | $1.57 avg | 26,500 | $42K | 100% |
| Filing → |
| CYTK | SELL | 2021-11-19 | $1.4M | — | Filing → |
| CYTK | SELL | 2021-07-21 | $403K | — | Filing → |
| CYTK | SELL | 2021-04-27 | $401K | — | Filing → |